Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: A population-based cohort study

Atherosclerosis

Volumn 220, Issue 2, 2012, Pages 569-574

  Schöttker, Ben ^a   Adamu, Mariam A ^a   Weck, Melanie N ^a   Müller, Heiko ^a   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cohort studies; Gastritis, atrophic; Helicobacter pylori; Myocardial infarction; Stroke

Indexed keywords

CAGA PROTEIN; PEPSINOGEN I; PEPSINOGEN II;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART INFARCTION; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREMATURE MORTALITY; PRIORITY JOURNAL; SEROLOGY; STROKE;

AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; FEMALE; GASTRITIS, ATROPHIC; GERMANY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPSINOGEN A; PEPSINOGEN C; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS;

EID: 84855969388     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.11.029     Document Type: Article

References (30)

1. World Health Organization The global burden of disease: 2004 update 2008, WHO Press, Geneva, Switzerland, p. 59.
2. Helfand M., Buckley D.I., Freeman M., et al. Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med 2009, 151(7):496-507.
3. Manolakis A., Kapsoritakis A.N., Potamianos S.P. A review of the postulated mechanisms concerning the association of Helicobacter pylori with ischemic heart disease. Helicobacter 2007, 12(4):287-297.
4. Suerbaum S., Michetti P. Helicobacter pylori infection. N Engl J Med 2002, 347(15):1175-1186.
5. Adamu M.A., Weck M.N., Gao L., et al. Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies. Eur J Epidemiol 2010, 25(7):439-448.
6. Kassarjian Z., Russell R.M. Hypochlorhydria: a factor in nutrition. Annu Rev Nutr 1989, 9:271-285.
7. Lewerin C., Jacobsson S., Lindstedt G., et al. Serum biomarkers for atrophic gastritis and antibodies against Helicobacter pylori in the elderly: implications for vitamin B12, folic acid and iron status and response to oral vitamin therapy. Scand J Gastroenterol 2008, 43(9):1050-1056.
8. Green T.J., Venn B.J., Skeaff C.M., et al. Serum vitamin B12 concentrations and atrophic gastritis in older New Zealanders. Eur J Clin Nutr 2005, 59(2):205-210.
9. Redeen S., Ryberg A., Petersson F., et al. Homocysteine levels in chronic gastritis and other conditions: relations to incident cardiovascular disease and dementia. Dig Dis Sci 2010, 55(2):351-358.
10. Antoniades C., Antonopoulos A.S., Tousoulis D., et al. Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials. Eur Heart J 2009, 30(1):6-15.
11. Zee R.Y., Mora S., Cheng S., et al. Homocysteine, 5,10-methylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women. Clin Chem 2007, 53(5):845-851.
12. Franceschi F., Niccoli G., Ferrante G., et al. CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases. Atherosclerosis 2009, 202(2):535-542.
13. Zhang S., Guo Y., Ma Y., et al. Relationship between the cytotoxin-associated gene-A status of H pylori strains and cerebral infarction in European Caucasians and Chinese Han: a meta-analysis. World J Gastroenterol 2008, 14(8):1286-1292.
14. Yang X., Zhao X., Gao Y., et al. Meta-analysis of the relationship between cytotoxin-associated gene-A and ischemic stroke subtypes. Neural Regen Res 2011, 6(1):34-40.
15. Haider A.W., Wilson P.W., Larson M.G., et al. The association of seropositivity to Helicobacter pylori. Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study. J Am Coll Cardiol 2002, 40(8):1408-1413.
16. Smieja M., Gnarpe J., Lonn E., et al. Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 2003, 107(2):251-257.
17. Elkind M.S., Ramakrishnan P., Moon Y.P., et al. Infectious burden and risk of stroke: the northern Manhattan study. Arch Neurol 2010, 67(1):33-38.
18. Strandberg T.E., Tilvis R.S., Vuoristo M., et al. Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general elderly population. BMJ 1997, 314(7090):1317-1318.
19. Strachan D.P., Mendall M.A., Carrington D., et al. Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the caerphilly prospective heart disease study. Circulation 1998, 98(13):1286-1290.
20. Adamu M.A., Weck M.N., Rothenbacher D., et al. Incidence and risk factors for the development of chronic atrophic gastritis: five year follow-up of a population-based cohort study. Int J Cancer 2011, 128(7):1652-1658.
21. Papamichael K.X., Papaioannou G., Karga H., et al. Helicobacter pylori infection and endocrine disorders: is there a link?. World J Gastroenterol 2009, 15(22):2701-2707.
22. Rosenstock S.J., Joergensen T., Bonnevie O., et al. Helicobacter pylori infection does not effect overall mortality in Denmark. A population-based prospective cohort study comprising 3,590 Danish adults. Gastroenterology 2000, 118(4):A726-A727. [abstract].
23. Danesh J., Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 1998, 316(7138):1130-1132.
24. Goll R., Gruber F., Olsen T., et al. Helicobacter pylori stimulates a mixed adaptive immune response with a strong T-regulatory component in human gastric mucosa. Helicobacter 2007, 12(3):185-192.
25. Gurfinkel E.P., de la Fuente R.L., Mendiz O., et al. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation 2002, 105(18):2143-2147.
26. Schimke K., Chubb S.A., Davis W.A., et al. Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study. Atherosclerosis 2010, 212(1):321-326.
27. Christodoulou D.K., Milionis H.J., Pappa P., et al. Association of Helicobacter pylori infection with cardiovascular disease - is it just a myth?. Eur J Intern Med 2011, 22(2):191-194.
28. Vaira D., Holton J., Menegatti M., et al. Blood tests in the management of Helicobacter pylori infection. Italian Helicobacter pylori Study Group. Gut 1998, 43(Suppl. 1):S39-S46.
29. Storskrubb T., Aro P., Ronkainen J., et al. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: the Kalixanda study. Scand J Gastroenterol 2008, 43(12):1448-1455.
30. Löw M., Stegmaier C., Ziegler H., et al. Epidemiological investigations of the chances of preventing, recognizing early and optimally treating chronic diseases in an elderly population (ESTHER study). Dtsch Med Wochenschr 2004, 129(49):2643-2647.